Loading...
Last deposits
-
Chiara Bastiancich, Emmanuel Snacel-Fazy, Samantha Fernandez, Stéphane Robert, Roberta Stacchini, et al.. Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment. Journal of experimental & clinical cancer research, 2024, 43 (1), pp.311. ⟨10.1186/s13046-024-03231-4⟩. ⟨hal-04833708⟩
-
Emmanuelle Uro-Coste, Arnault Tauziède-Espariat, Charlotte Dubucs, Dan Christian Chiforeanu, Aurore Siegfried, et al.. Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular. Brain Pathology, 2024, 34 (3), pp.e13223. ⟨10.1111/bpa.13223⟩. ⟨hal-04416149⟩
-
-
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, Stéphane Robert, Florian Correard, et al.. Extending trastuzumab-coated immunoliposome to HER2 negative breast cancer models : a proof of concept study. Journées GPCO (Le Groupe de Pharmacologie Clinique Oncologique), Nov 2018, Villejuif, France. ⟨hal-04727223⟩
-
Caroline Hertler, Jörg Felsberg, Dorothee Gramatzki, Emilie Le Rhun, Jennifer Clarke, et al.. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419). European Journal of Cancer, 2023, 189, pp.112913. ⟨10.1016/j.ejca.2023.05.002⟩. ⟨hal-04207063⟩
-
Nathalie Sakakini, Laurent Turchi, Aurélie Bergon, Hélène Holota, Samah Rekima, et al.. A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells. Journal of Biological Chemistry, 2016, 291 (20), pp.10684-10699. ⟨10.1074/jbc.M116.720698⟩. ⟨hal-01460121⟩
-
-
Lakshmi Pallavi Ganipineni, Bernard Ucakar, Nicolas Joudiou, John Bianco, Pierre Danhier, et al.. Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma. International Journal of Nanomedicine, 2018, Volume 13, pp.4509-4521. ⟨10.2147/IJN.S165184⟩. ⟨hal-02076755⟩
-
-
Katja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, Elizabeth Schepke, Teresa de Rojas, et al.. Therapeutic implications of improved molecular diagnostics for rare CNS-embryonal tumor entities: results of an international, retrospective study. Neuro-Oncology, 2021, 23 (9), pp.1597-1611. ⟨10.1093/neuonc/noab136⟩. ⟨hal-03253034⟩
-
Martin van den Bent, Marica Eoli, Juan Manuel Sepulveda, Marion Smits, Annemiek Walenkamp, et al.. INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma. Neuro-Oncology, 2019, 22 (5), pp.684-693. ⟨10.1093/neuonc/noz222⟩. ⟨hal-02441092⟩
-
Louis-Marie Terrier, Luc Bauchet, Valérie Rigau, Aymeric Amelot, Sonia Zouaoui, et al.. Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuro-Oncology, 2017, 19 (5), pp.678-688. ⟨10.1093/neuonc/now186⟩. ⟨hal-02051153⟩
-
-
Coline Montégut, Jean-Sébastien Guillamo, François Ducray, Caroline Dehais, Cohen-Jonathan Moyal Elisabeth, et al.. Predictive geriatric factors in elderly patients treated for idh-mutant high-grade gliomas: a French Pola network study. Neuro-Oncology, 2021, 23 (6), pp.153. ⟨10.1093/neuonc/noab196.600⟩. ⟨hal-03600574⟩
-